Affinity Asset Advisors »

Oruka Therapeutics shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Oruka Therapeutics shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Oruka Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Oruka Therapeutics held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oruka Therapeutics by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $8.6M 350k 24.51

More positions owned by Affinity Asset Advisors

Xenon Pharmaceuticals (XENE)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Cassava Sciences Put Option (SAVA)
Apogee Therapeutics (APGE)
Nuvalent Inc-a (NUVL)
Arcellx Common Stock (ACLX)
Alkermes SHS (ALKS)
Madrigal Pharmaceuticals (MDGL)
Crinetics Pharmaceuticals In (CRNX)
Nurix Therapeutics (NRIX)
Vera Therapeutics Cl A (VERA)
Verona Pharma Sponsored Ads (VRNA)
Autolus Therapeutics Spon Ads (AUTL)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Inozyme Pharma (INZY)

View all positions for Affinity Asset Advisors

Top funds holding Oruka Therapeutics

Fairmount Funds Management
VR Adviser
Commodore Capital
Perceptive Advisors
Avidity Partners Management
Franklin Resources
Paradigm Biocapital Advisors
Braidwell
Dr. Jeffrey R. Jay, M.D.
Point72 Asset Management
Frazier Life Sciences Management
Redmile Group
Woodline Partners
Affinity Asset Advisors
Driehaus Capital Management

View all funds holding Oruka Therapeutics